The Hsp90-specific inhibitor, geldanamycin, blocks CD28-mediated activation of human T lymphocytes.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Life Science

• Publication date

  1998-08-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0024-3205(98)00352-XPMID 9747895
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Associate Editor: D. Shugar The 90-kDa Molecular Chaperone Family: Structure, Function, and Clinical Applications. A Comprehensive Review

  1998cited by this paper
• Two chaperone sites in Hsp90 differing in substrate specificity and ATP dependence.

  1998cited by this paper
• Proteins, RNAs and chaperones in enzyme evolution: a folding perspective.

  1997cited by this paper
• Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone.

  1997cited by this paper
• T cell antigen receptor dependent signalling in human lymphocytes: cholera toxin inhibits interleukin-2 receptor expression but not interleukin-2 synthesis by preventing activation of a protein kinase C isotype, PKC-α

  1997cited by this paper
• In vitro evidence that hsp90 contains two independent chaperone sites

  1997cited by this paper
• T cell antigen receptor dependent signalling in human lymphocytes: cholera toxin inhibits interleukin-2 receptor expression but not interleukin-2 synthesis by preventing activation of a protein kinase C isotype, PKC-alpha.

  1997cited by this paper
• CD28-mediated activation of resting human T cells without costimulation of the CD3/TCR complex.

  1997cited by this paper
• The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase.

  1997cited by this paper
• The hsp90-binding Antibiotic Geldanamycin Decreases Raf Levels and Epidermal Growth Factor Signaling without Disrupting Formation of Signaling Complexes or Reducing the Specific Enzymatic Activity of Raf Kinase*

  1997cited by this paper
• Co-stimulation in T cell responses.

  1997cited by this paper
• CD28‐mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: Evidence for functionally distinct forms of CD28

  1997cited by this paper
• In vivo functions of the Saccharomyces cerevisiae Hsp90 chaperone.

  1997cited by this paper
• Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent.

  1997cited by this paper
• Molecular chaperones in cellular protein folding

  1996cited by this paper
• Hsp90-mediated folding of the lymphoid cell kinase p56lck.

  1996cited by this paper
• CD28/B7 system of T cell costimulation.

  1996cited by this paper
• Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.

  1994cited by this paper
• Assisting spontaneity: the role of Hsp90 and small Hsps as molecular chaperones.

  1994cited by this paper
• Differential regulation of proto-oncogenes c-jun and c-fos in T lymphocytes activated through CD28.

  1994cited by this paper
• JNK is involved in signal integration during costimulation of T lymphocytes.

  1994cited by this paper
• Functional expression of human CD28 in murine T cell hybridomas.

  1994cited by this paper
• CD28-stimulated IL-2 gene expression in Jurkat T cells occurs in part transcriptionally and is cyclosporine-A sensitive.

  1992cited by this paper
• Analysis of the immunoregulatory capacity of anti-alpha/beta-TCR and anti-CD3 monoclonal antibodies.

  1991cited by this paper
• Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus

  1986cited by this paper

• Expression of membrane Hsp90 is a molecular signature of T cell activation

  2022cites this paper
• Expression of extracellular Hsp90 is a molecular signature of T cell activation, providing a means to image and target T Cell activation in autoimmune disease

  2021cites this paper
• Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer

  2020cites this paper
• Activity of Human T Lymphocytes and NK Regulation of Phenotype and Functional Heat Shock Protein 90 Is Critical for

  2017cites this paper
• Radiotherapy plus Heat Shock Protein 90 Inhibition: Sensitizing Cancer Cells to Irradiation-Induced Cell Death and Enhancing their Immunogenicity

  2017cites this paper
• Gene expression regulation by heat-shock proteins: the cardinal roles of HSF1 and Hsp90.

  2017cites this paper
• Heat shock protein 90 inhibitors induce functional inhibition of human natural killer cells in a dose-dependent manner

  2016cites this paper
• Targeting the heat shock response in combination with radiotherapy: Sensitizing cancer cells to irradiation-induced cell death and heating up their immunogenicity.

  2015cites this paper
• Regulatory role of the 90-kDa-heat-shock protein (Hsp90) and associated factors on gene expression.

  2014cites this paper
• Heat Shock Protein 90 Is Critical for Regulation of Phenotype and Functional Activity of Human T Lymphocytes and NK Cells

  2013cites this paper
• CellsActivity of Human T Lymphocytes and NK Regulation of Phenotype and Functional Heat Shock Protein 90 Is Critical for

  2013cites this paper
• and T Cell Nonreceptor Protein Tyrosine Function Protein 90-Binding Agent, on T Cell Effects of Geldanamycin, a Heat-Shock

  2013cites this paper
• Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic stem cell transplantation: Will it be possible to combine these strategies with retransplantation or donor lymphocyte infusions?

  2012cites this paper
• Tumor-intrinsic and tumor-extrinsic factors impacting hsp90- targeted therapy.

  2012cites this paper
• Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases

  2011cites this paper
• Emerging pathways of non-genomic glucocorticoid (GC) signalling in T cells.

  2010cites this paper
• Heat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancer.

  2009cites this paper
• Heat shock protein 90 - a potential target in the treatment of human acute myelogenous leukemia.

  2009cites this paper
• Neuroprotective Features Of Hsp90 Inhibitors Exhibiting Anti-Inflammatory Actions: Implications For Multiple Sclerosis

  2008cites this paper
• This information is current as Shock Protein 90 Inhibition on Dendritic Cell Phenotypic and Functional Effects of Heat and

  2007cites this paper
• Phenotypic and Functional Effects of Heat Shock Protein 90 Inhibition on Dendritic Cell

  2007cites this paper
• Molekulare Effekte der Immunmodulation mit einem anti-CD4-Antikörper

  2004cites this paper
• Geldanamycin, a heat shock protein 90‐binding agent, disrupts Stat5 activation in IL‐2‐stimulated cells

  2004influential citation
• The role of ubiquitin, heat shock proteins, and inducible proteasome subunits in major histocompatibility class I antigen presentation

  2004cites this paper
• Enhancement of complement-induced cell lysis: a novel mechanism for the anticancer effects of Hsp90 inhibitors.

  2004cites this paper
• High affinity binding of Hsp90 is triggered by multiple discrete segments of its kinase clients.

  2003cites this paper
• Inhibition of arachidonic acid release from human peripheral mononuclear cells by heat shock treatment and geldanamycin.

  2002cites this paper
• T cells and aging, January 2002 update.

  2002cites this paper
• Geldanamycin inhibits NF-kappaB activation and interleukin-8 gene expression in cultured human respiratory epithelium.

  2001cites this paper
• Kinases and T Cell Nonreceptor Protein Tyrosine FunctionProtein 90-Binding Agent , on T Cell Effects of Geldanamycin , a Heat-Shock

  2000influential citation
• The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation

  2000cites this paper
• Effects of Geldanamycin, a Heat-Shock

  2000influential citation
• Effects of Geldanamycin, a Heat-Shock Protein 90-Binding Agent, on T Cell Function and T Cell Nonreceptor Protein Tyrosine Kinases1

  2000influential citation
• T cells and aging (update february 1999).

  1999cites this paper